The company markets two OTC products under its Mucinex brand in the United States.
Its products include Mucinex SE, a single-ingredient guaifenesin product, and Mucinex DM, a guaifenesin and the cough suppressant dextromethorphan HBr combination product.
In addition, Adams Respiratory Therapeutics developed four respiratory products that are approved by the U.
S. Food and Drug Administration.
The company, formerly known as Adams Laboratories, Inc., was founded by John Q.
Adams Respiratory Therapeutics is headquartered in Chester, New Jersey.